# Contact Telehealth TB-500: Editorial Inquiries | TB-500

> Contact Telehealth TB-500 with editorial corrections or citation questions about the TB-500 and thymosin beta-4 digest. We do not provide medical advice, dosing, or any product.

For editorial corrections and citation questions about the TB-500 digest. Not a clinical channel — no medical advice, no dosing, no product, no prescriptions.

## Editorial inquiries only

This contact channel is for editorial matters about the TB-500 and thymosin beta-4 digest: a citation that needs checking, a study we should add, a number that looks wrong, or a regulatory entry that has moved on the FDA record. If a source has been superseded or a link has broken, that is exactly the kind of note we want.

What this channel is not: it is not a clinical service. We cannot provide medical advice, dosing, administration guidance, or a prescription, and we cannot direct you to a vendor, pharmacy, clinic, or telehealth provider — the site names none, by design. Those questions belong with an appropriately licensed professional.

## Send a note

Use the form below to reach the editorial desk. Please include a specific page and, where relevant, the citation number you are writing about — it makes corrections faster and more accurate.

We read every message about the accuracy of the record. We do not respond to requests for sourcing, dosing, or purchase of any substance, and we do not keep a mailing list or sell contact details.

---

A risograph reading of the TB-500 record, where the Ac-LKKTETQ fragment overlaps its parent protein thymosin beta-4 the way two inks overlap on the page — each finding plated to its study, the human-evidence panel left blank, and the FDA 503A standing printed first; no clinic behind the press and nothing here dispensed or sold.